Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 14 studies | 58% ± 24% | |
oligodendrocyte | 13 studies | 36% ± 14% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 26% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 9821.87 | 2631 / 2642 | 99% | 796.17 | 697 / 705 |
skin | 0% | 0 | 0 / 1809 | 46% | 21.08 | 218 / 472 |
kidney | 0% | 0 | 0 / 89 | 18% | 3.71 | 161 / 901 |
peripheral blood | 10% | 131.74 | 94 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 8% | 1.00 | 6 / 80 |
lung | 1% | 27.33 | 3 / 578 | 2% | 0.20 | 21 / 1155 |
thymus | 0% | 1.79 | 1 / 653 | 2% | 1.37 | 13 / 605 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.47 | 1 / 45 |
adrenal gland | 0% | 0 | 0 / 258 | 2% | 0.22 | 5 / 230 |
breast | 0% | 0 | 0 / 459 | 2% | 0.31 | 17 / 1118 |
bladder | 0% | 0 | 0 / 21 | 1% | 0.09 | 4 / 504 |
ovary | 0% | 0 | 0 / 180 | 1% | 0.29 | 3 / 430 |
prostate | 0% | 0 | 0 / 245 | 1% | 0.08 | 3 / 502 |
pancreas | 0% | 0 | 0 / 328 | 1% | 0.03 | 1 / 178 |
spleen | 0% | 3.15 | 1 / 241 | 0% | 0 | 0 / 0 |
uterus | 0% | 0 | 0 / 170 | 0% | 0.01 | 1 / 459 |
heart | 0% | 1.37 | 1 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
esophagus | 0% | 0 | 0 / 1445 | 0% | 0 | 0 / 183 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
intestine | 0% | 0 | 0 / 966 | 0% | 0 | 0 / 527 |
liver | 0% | 0 | 0 / 226 | 0% | 0 | 0 / 406 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
stomach | 0% | 0 | 0 / 359 | 0% | 0 | 0 / 286 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007423 | Biological process | sensory organ development |
GO_0014003 | Biological process | oligodendrocyte development |
GO_0061564 | Biological process | axon development |
GO_0048663 | Biological process | neuron fate commitment |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0070888 | Molecular function | E-box binding |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | OLIG1 |
Protein name | Oligodendrocyte transcription factor 1 (Oligo1) (Class B basic helix-loop-helix protein 6) (bHLHb6) (Class E basic helix-loop-helix protein 21) (bHLHe21) Oligodendrocyte transcription factor 1 |
Synonyms | BHLHE21 BHLHB6 |
Description | FUNCTION: Promotes formation and maturation of oligodendrocytes, especially within the brain. Cooperates with OLIG2 to establish the pMN domain of the embryonic neural tube (By similarity). . |
Accessions | ENST00000426947.5 ENST00000382348.2 H7C404 Q8TAK6 |